- Report
- June 2023
- 110 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- April 2024
- 193 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- April 2024
- 194 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- November 2023
- 142 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- February 2024
- 114 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- October 2023
- 145 Pages
Global
From €3040EUR$3,150USD£2,608GBP
- Report
- October 2023
- 144 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- October 2023
- 146 Pages
Global
From €3405EUR$3,528USD£2,921GBP
€4006EUR$4,150USD£3,436GBP
- Report
- January 2024
- 155 Pages
United States
From €2403EUR$2,490USD£2,062GBP
- Report
- February 2024
- 85 Pages
North America
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 90 Pages
Europe
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2021
- 117 Pages
United States
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2023
- 80 Pages
Asia Pacific
From €4585EUR$4,750USD£3,933GBP
- Report
- October 2019
- 113 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- December 2022
- 142 Pages
Global
From €3405EUR$3,528USD£2,921GBP
€4006EUR$4,150USD£3,436GBP
- Report
- June 2022
- 142 Pages
Global
From €3475EUR$3,600USD£2,981GBP
Desflurane is a volatile anesthetic drug used in the induction and maintenance of general anesthesia. It is a halogenated ether, and is one of the most commonly used inhalational anesthetics in modern clinical practice. Desflurane is a colorless liquid at room temperature, with a boiling point of 23.5°C. It has a low blood/gas partition coefficient, meaning it is rapidly eliminated from the body, and has a low solubility in blood, making it suitable for use in rapid-sequence induction. Desflurane is also known for its low incidence of postoperative nausea and vomiting.
Desflurane is available in a variety of formulations, including premixed solutions, vaporizers, and inhalers. It is manufactured by several companies, including Baxter, Hospira, and AbbVie. Other companies involved in the production and distribution of desflurane include B. Braun, Fresenius Kabi, and Merck. Show Less Read more